15% of 2017-2020 melanoma patients had genetic mutations, significantly increasing inherited gene risk, per a Cleveland Clinic study.

A study from Cleveland Clinic reveals that family history or inherited genes play a larger role in melanoma risk than previously thought, with 15% of patients diagnosed with melanoma between 2017 and 2020 showing mutations in cancer susceptibility genes. Previous studies suggested only 2-2.5% of cases were genetic. Genetic testing could help physicians proactively identify and treat families with inherited genes.